Patents by Inventor Bazan Fernando J.

Bazan Fernando J. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MAMMALIAN CX3C CHEMOKINE ANTIBODIES
    Publication number: 20120225482
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: April 23, 2012
    Publication date: September 6, 2012
    Applicant: Schering Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, Bazan Fernando J., Thomas P. Schall, Albert Zlotnik
  • Mouse CX3C chemokine polypeptides
    Patent number: 8173117
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: May 8, 2012
    Assignee: Schering Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B Bacon, Bazan Fernando J., Thomas P. Schall, Albert Zlotnik
  • MAMMALIAN CX3C CHEMOKINE ANTIBODIES
    Publication number: 20110189123
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: July 9, 2010
    Publication date: August 4, 2011
    Applicant: SCHERING CORPORATION
    Inventors: GERARD T. HARDIMAN, DEVORA L. ROSSI, KEVIN B. BACON, BAZAN FERNANDO J., THOMAS J. SCHALL, ALBERT ZLOTNIK
  • MAMMALIAN CX3C CHEMOKINE ANTIBODIES
    Publication number: 20090317398
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: July 28, 2009
    Publication date: December 24, 2009
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, Bazan Fernando J., Thomas P. Schall, Albert Zlotnik
  • Mammalian CX3C chemokine
    Patent number: 6566503
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Grant
    Filed: January 25, 2001
    Date of Patent: May 20, 2003
    Assignee: Schering Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B Bacon, Bazan Fernando J., Thomas J. Schall, Albert Zlotnik
  • Mammalian CX3C chemokine genes
    Publication number: 20030027990
    Abstract: Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: January 25, 2001
    Publication date: February 6, 2003
    Applicant: Schering Corporation, a New Jersey Corporation
    Inventors: Gerard T. Hardiman, Devora L. Rossi, Kevin B. Bacon, Bazan Fernando J., Thomas P. Schall, Albert Zlotnik
  • Mammalian receptors for interleukin-10
    Patent number: 6423500
    Abstract: Receptor components for IL-10 are isolated and characterized. The amino acid sequence and nucleic acid encoding various species variants of the receptors are disclosed. Uses of the purified receptor gene and polypeptide are disclosed, including means for screening for agonists and antagonists of the receptor ligands, for producing diagnostic or therapeutic reagents, and for producing antibodies. Therapeutic or diagnostic reagents and kits are also provided.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: July 23, 2002
    Assignee: Schering Corporation
    Inventors: Kevin W. Moore, Ying Liu, Alice Suk-Yue Ho, Di-Hwei Hsu, Bazan Fernando J., Jimmy C. Tan, Chuan-Chu Chou